Recent problems with paracervical vasopressin: A possible synergistic reaction with nicotine

Medical Hypotheses

Volumn 47, Issue 1, 1996, Pages 19-21

  Groudine, S B ^a   Morley, J N ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; VASOPRESSIN;

ARTICLE; BLEEDING; BRADYCARDIA; CASE REPORT; DRUG POTENTIATION; FEMALE; HUMAN; HYPOTENSION; HYPOTHESIS; PRIORITY JOURNAL; REGIONAL PERFUSION; SMOKING; SURGERY;

EID: 0030036952     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90036-5     Document Type: Article

References (7)

1. 2-vasopressinergic receptors. Am J Physiol 1988; 255: H261-H265.
2. Martin J D, Shenk L G. Intraoperative myocardial infarction after paracervical vasopressin infiltration. Anesth Analg 1994; 79: 1201-1202.
3. Alexander G D, Brown M. A safe dose of vasopressin for paracervical infiltration. Anesth Analg 1995; 81: 428.
4. Ruskin A. Pitressin test of coronary insufficiency. Am Heart J 1947; 34: 569-579.
5. Slotnik I L, Teigland J D. Cardiac accidents following vasopressin injection (Pitressin*). JAMA 1951; 146: 1126-1129.
6. Benowitz N L. Smoking-induced coronary vasoconstriction: implications for therapeutic use of nicotine. JACC 1993; 22: 648-649.
7. Quillen J E, Rossen J D, Oskarsson H J, Minor R L, Lopez A G, Winniford M D. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. JACC 1993; 22: 642-647.